There are four country ETFs down less than 1% since Liberation Day: South Korea ( EWY ), Switzerland ( EWL ), New Zealand ( ...

Consumer price inflation fell to 2.4% in March, surprising analysts who expected a rise, but future inflation concerns remain ...

Northland Power's minimal U.S. exposure and 90% contracted revenue make it resilient to tariffs and economic slowdowns. Click ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

Tevogen Bio faces hurdles with unclear COVID-19 therapy demand, ambitious projections, and risks ahead. Click here to read an ...

Apple Inc.'s market value declines amid tariff controversy. Discover why its valuation remains unattractive and growth ...

Dr. Maguire is an ardent, experienced value investor. Most of his career has been spent as a healthcare executive and business owner, caring for patients diagnosed with cancer in coastal North ...

The 200DMA Signal suggests S&P 500 Index losses amidst U.S.-China tensions. Click for my look at technical triggers for the ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Celestica reports 21% YoY revenue growth in CY 2024, driven by CCS expansion. Click here to find out why CLS stock is a Buy.

NVR faces short-term challenges but thrives on a 3.5M U.S. housing shortage. With a 25% upside, discover why it's a long-term ...